Crossmark

Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care

Crossref DOI link: https://doi.org/10.1186/s12916-022-02272-w

Published Online: 2022-03-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Withrow, Diana R. http://orcid.org/0000-0002-9757-040X
Shine, Brian http://orcid.org/0000-0002-1016-8638
Oke, Jason http://orcid.org/0000-0003-3467-6677
Tamm, Andres http://orcid.org/0000-0003-0770-998X
James, Tim http://orcid.org/0000-0002-5382-9838
Morris, Eva http://orcid.org/0000-0002-1075-6544
Davies, Jim http://orcid.org/0000-0003-4664-6862
Harris, Steve http://orcid.org/0000-0002-0899-325X
East, James E. http://orcid.org/0000-0001-8035-3700
Nicholson, Brian D. http://orcid.org/0000-0003-0661-7362
License Information

Text and Data Mining valid from 2022-03-15

Version of Record valid from 2022-03-15
More Information

Article History

Received: 9 December 2021

Accepted: 24 January 2022

First Online: 15 March 2022

Declarations

:

: This study was conducted as a service evaluation with registration, review, and approval process within the OUH Datix governance structure (Service evaluation registration identifier: CSS-BIO-3-4730). As service evaluation, this work is not subject to the Department of Health’s UK Policy Framework for Health and Social Care Research (2017). The Sponsorship and Ethics Lead within the Research Governance, Ethics and Assurance Team, in the Research Support Office at the University of Oxford has confirmed that it requires neither sponsorship nor research ethics review.

: Not applicable

: The authors have no competing interests to declare.

Document is current

Any future updates will be listed below